Use of statins in adults older than 75 years - Reply

JAMA - Journal of the American Medical Association

Volumn 317, Issue 10, 2017, Pages 1081-

  Gurwitz, Jerry H ^a   Go, Alan S ^b   Fortmann, Stephen P ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b DIVISION OF RESEARCH   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; CARDIOVASCULAR MORTALITY; CLINICAL PRACTICE; CORONARY ARTERY ATHEROSCLEROSIS; DRUG USE; GERIATRIC CARE; HUMAN; LETTER; MORBIDITY; PATIENT RISK; PRACTICE GUIDELINE; RISK ASSESSMENT; SHARED DECISION MAKING; ADULT; CARDIOVASCULAR DISEASES; PRIMARY PREVENTION;

ADULT; CARDIOVASCULAR DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PRIMARY PREVENTION;

EID: 85015587002     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.0385     Document Type: Letter

References (1)

1. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014;129(25)(suppl 2):S1-S45.